Abstract
The familial periodic paralyses (PP) were commonly considered to be benign diseases since frequency and severity of the paralytic attacks decrease in adulthood. However, with increasing age, a third of the patients develop permanent weakness and muscle degeneration with fatty replacement. Another complication, cardiac arrhythmia, can result from the dyskalemia during paralytic attacks. The familial PP are typical dominant ion channelopathies: the function of the mutant muscular channel is compensated in the interictal state but defective under certain conditions which then cause flaccid weakness. A triggering factor is the level of serum potassium, the extracellular ion decisive for membrane excitability. In hyper- and hypokalemic periodic paralysis, the mutations are specifically located in the voltage-gated sodium and calcium channels which are essential for action potential generation or excitation-contraction coupling. The common mechanism for the membrane inexcitability during paralytic attacks is a transient membrane depolarization that inactivates the sodium channels which are then no longer available for action potential generation. For the third PP type, the Andersen syndrome, the responsible gene is also expressed in cardiac muscle, and, independently of paralytic attacks, the hazard of ventricular arrhythmias is inherent. The gene product, an inwardly rectifying potassium channel, is responsible for maintaining the resting membrane potential, and all known mutations cause dominant–negative effects on the tetrameric channel complexes. In this article the clinical consequences of the mutations and the therapeutic strategies for all three types of PP are reported.
Similar content being viewed by others
References
Abbott GW, Butler MH, Bendahhou S, Dalakas MC, Ptacek LJ, Goldstein SA (2001) MiRP2 forms potassium channels in skeletal muscle with Kv3.4 and is associated with periodic paralysis. Cell 104:217–231
Andelfinger G, Tapper AR, Welch RC, Vanoye CG, George AL Jr, Benson DW (2002) KCNJ2 mutation results in Andersens syndrome with sex-specific cardiac and skeletal muscle phenotypes. Am J Hum Genet 71:663–668
Bendahhou S, Donaldson MR, Plaster NM, Tristani-Firouzi M, Fu YH, Ptacek LJ (2003) Defective potassium channel Kir2.1 trafficking underlies Andersen-Tawil syndrome. J Biol Chem 278:51779–51785
Fontaine B, Khurana TS, Hoffman EP, Bruns GAP, Haines JL, Trofatter JA, Hanson MP, Rich J, McFarlane H, McKenna-Yacek D, Gusella JF, Brown RH (1990) Hyperkalemic periodic paralysis and the adult muscle sodium channel alpha-subunit gene. Science 250:1000–1002
Fontaine B, Vale-Santos JE, Jurkat-Rott K, Reboul J, Plassart E, Rime CS, Elbaz A, Heine R, Guimaraes J, Weissenbach J, Baumann N, Fardeau M, Lehmann-Horn F (1994). Mapping of the hypokalaemic periodic paralysis (HypoPP) locus to chromosome 1q31–32 in three European families. Nature Genet 6:267–272
Hayward LJ, Brown RH Jr, Connon SC (1996) Inactivation defects caused by myotonia-associated mutations in the sodium channel III-IV linker. J Gen Physiol 107:559–576
Jurkat-Rott K, Lehmann-Horn F, Elbaz A, Heine R, Gregg RG, Hogan K, Powers P, Lapie P, Vale-Santos JE, Weissenbach J, Fontaine B (1994) A calcium channel mutation causing hypokalemic periodic paralysis. Hum Mol Gen 3:1415–1419
Jurkat-Rott K, Uetz U, Pika-Hartlaub U, Powell J, Fontaine B, Melzer W, Lehmann-Horn F (1998) Calcium currents and transients of native and heterologously expressed mutant skeletal muscle DHP receptor α1 subunits (R528H). FEBS Lett 423:198–204
Jurkat-Rott K, Mitrovic N, Hang C, Kuzmenkin A, Iaizzo P, Herzog J, Lerche H, Nicole N, Vale-Santos J, Chauveau D, Fontaine B, Lehmann-Horn F (2000) Voltage sensor sodium channel mutations cause hypokalemic periodic paralysis type 2 by enhanced inactivation and reduced current. Proc Natl Acad Sci USA 97:9549–9554
Jurkat-Rott K, Lehmann-Horn F (2004) Periodic paralysis mutation MiRP2-R83H in controls: interpretations and general recommendation. Neurology 62:1012–1015
Kuzmenkin A, Muncan V, Jurkat-Rott K, Hang C, Lerche H, Lehmann-Horn F, Mitrovic N (2002) Enhanced inactivation and pH sensitivity of Na+ channel mutations causing hypokalemic periodic paralysis type II. Brain 125:835–843
Lehmann-Horn F, Kuther G, Ricker K, Grafe P, Ballanyi K, Rüdel R (1987) Adynamia episodica hereditaria with myotonia: A non-inactivating sodium current and the effect of extracellular pH. Muscle Nerve 10:363–374
Lehmann-Horn F, Jurkat-Rott K (1999) Voltage-gated ion channels and hereditary disease. Physiol Rev 79:1317–1371
Lehmann-Horn F, Rüdel R, Jurkat-Rott K (2004) Chapter 46: Nondystrophic myotonias and periodic paralyses. In: Engel AG, Franzini-Armstrong C (ed) Myology. McGraw-Hill, New York, 3rd edition, pp 1257–1300
Morrill JA, Cannon SC (1999) Effects of mutations causing hypokalaemic periodic paralysis on the skeletal muscle L-Type Ca2+ channel expressed in Xenopus laevis oocytes. J Physiol (London) 520:321–336
Plaster NM, Tawil R, Tristani-Firouzi M, Canun S, Bendahhou S, Tsunoda A, Donaldson MR, Iannaccone ST, Brunt E, Barohn R, Clark J, Deymeer F, George AL Jr, Fish FA, Hahn A, Nitu A, Özdemir C, Serdaroglu P, Subramony SH, Wolfe G, Fu YH, Ptáček LJ (2001) Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen’s syndrome. Cell 105:511–519
Rojas CV, Wang J, Schwartz L, Hoffman EP, Powell BR, Brown RH Jr (1991) A Met-to-Val mutation in the skeletal muscle sodium channel -subunit in hyperkalemic periodic paralysis. Nature 354:387–389
Rüdel R, Lehmann-Horn F, Ricker K, Küther G (1984) Hypokalemic periodic paralysis: in vitro investigation of muscle fiber membrane parameters. Muscle Nerve 7:110–120
Ruff RL (1999) Insulin acts in hypokalemic periodic paralysis by reducing inward rectifier K+ current. Neurology 53:1556–1563
Sansone V, Griggs RC, Meola G, Ptáček LJ, Barohn R, Iannaccone S, Bryan W, Baker N, Janas SJ, Scott W, Ririe D, Tawil R (1997) Andersens syndrome: a distinct periodic paralysis. Ann Neurol 42:305–312
Sternberg D, Tabti N, Fournier E, Hainque B, Fontaine B (2003) Lack of association of the potassium channel-associated peptide MiRP2-R83H variant with periodic paralysis. Neurology 61:857–859
Struyk AF, Scoggan KA, Bulman DE, Cannon SC (2000) The human skeletal muscle Na channel mutation R669H associated with hypokalemic periodic paralysis enhances slow inactivation. J Neurosci 20:8610–8617
Tawil R, Ptáček LJ, Pavlakis SG, DeVivo DC, Penn AS, Özdemir C, Griggs RC (1994) Andersens’s syndrome: potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic features. Ann Neurol 35:326–330
Tristani-Firouzi M, Jensen JL, Donaldson MR, Sansone V, Meola G, Hahn A, Bendahhou S, Kwiecinski H, Fidzianska A, Plaster N, Fu YH, Ptáček LJ, Tawil R (2002) Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersens syndrome). J Clin Invest 110:381–388
Venance SL, Cannon SC, Fialho D, Fontaine B, Hanna MG, Ptacek LJ, Tristani-Firouzi M, Tawil R, Griggs RC, CINCH investigators (2006) The primary periodic paralyses: diagnosis, pathogenesis and treatment. Brain 129:8–17
Vicart S, Sternberg D, Fournier E, Ochsner F, Laforet P, Kuntzer T, Eymard B, Hainque B, Fontaine B (2004) New mutations of SCN4A cause a potassium-sensitive normokalemic periodic paralysis. Neurology 63:2120–2127
Wagner S, Lerche H, Mitrovic N, Heine R, George AL, Lehmann-Horn F (1997) A novel sodium channel mutation causing a hyperkalemic paralytic and paramyotonic syndrome with variable clinical expressivity. Neurology 49:1018–1025
Weber M-A, Nielles-Vallespin S, Essig M, Jurkat-Rott K, Kauczor H-U, Lehmann-Horn F (2006) Muscle Na+ channelopathies: MR1 detects intracellular 23Na accumulation during episodic weakness. Neurology 67:1151–1158
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jurkat-Rott, K., Lehmann-Horn, F. Paroxysmal muscle weakness - the familial periodic paralyses. J Neurol 253, 1391–1398 (2006). https://doi.org/10.1007/s00415-006-0339-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-006-0339-0